Infectious Diseases in Children Current Issue
The following articles appeared in the print edition of Infectious Diseases in Children.
Table of Contents
- ‘Media hype’ distorts public view on infectious diseases
-
- Increased congressional funding supports antibiotic resistance effort
- Recent deaths, microcephaly cases in Brazil linked to Zika virus infection
- TB Alliance announces first-ever, fixed-dose TB drug designed for children
- WHO: Young children account for 30% of foodborne illness-related deaths
- FDA advisory committee recommends approval for Cinqair in adults only
- FDA advisory committee recommends banning OTC codeine sold for children
- FDA approves QuilliChew ER for pediatric ADHD
- FDA proposes tanning bed age restrictions, safety measures
-
- Adolescents recently prescribed ADHD medication at greater risk for bullying
- Antidepressant use in second, third trimester may increase risk for autism
- Atopic disease associated with childhood anemia
- Early administration of antibiotics helps prevent severe lower respiratory infection in children
- Elimination of vaccine exemptions serves children's best interests
- Infection control in day care centers crucial to reducing burden of infection
- Measles, other infectious diseases likely to return without vaccine adherence
- Misinformation, false perception of risk contribute to vaccine hesitancy
-
- The cost of care: Surging drug prices in the physician spotlight Edward A. Bell, PharmD, BCPS
- ‘Sandpaper’ rash spreading over torso, limbs in a 15-year-old female Emily Osier, MD; Andrew C. Krakowski, MD
- Widespread appearance of violaceous lesions in newborn male James H. Brien, DO